Aeon Strategies Ltd. AEON

AEON Company Overview

Data inconclusive based on available public sources regarding the entity “Cloud3 Ventures Inc.” associated with the ticker symbol “AEON.” Public market references for the ticker “AEON” are more consistently associated with AEON Biopharma, Inc., a U.S.-based clinical-stage biopharmaceutical company focused on the development of botulinum toxin therapeutics for neurological and related disorders. Because multiple databases and market references do not consistently identify “Cloud3 Ventures Inc.” as the primary issuer tied to the ticker, a fully verified company overview cannot be provided without risk of misidentification.

Based on publicly available SEC filings and exchange records available through major financial databases up to recent reporting periods, AEON Biopharma, Inc. has operated in the biotechnology and specialty therapeutics sector, with development programs centered on botulinum toxin applications for chronic neurological conditions. The company’s business model has historically relied on clinical development milestones, intellectual property licensing arrangements, and capital markets financing rather than diversified commercial revenue streams. Information specifically linking these operations to “Cloud3 Ventures Inc.” remains inconclusive based on available public sources.